<DOC>
	<DOCNO>NCT01200407</DOCNO>
	<brief_summary>The purpose study determine safety , tolerability efficacy Amlodipine Olmesartan medoxomil among Hypertensive Filipino patient .</brief_summary>
	<brief_title>Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Amlodipine Besylate , Olmesartan Medoxomil Drug Combination</mesh_term>
	<criteria>Filipino hypertensive subject age 1865 year old whether naive currently take antihypertensive monotherapy use CCBs ARBs want shift fix dose combination drug Patients contraindication component fix drug ( amlodipine olmesartan medoxomil ) malignant secondary hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>fix drug combination</keyword>
	<keyword>Filipinos</keyword>
	<keyword>Amlodipine</keyword>
	<keyword>Olmesartan medoxomil</keyword>
	<keyword>uncontrolled hypertension</keyword>
	<keyword>difficult treat hypertension</keyword>
</DOC>